<DOC>
	<DOCNO>NCT01051440</DOCNO>
	<brief_summary>There report stimulant may effective bipolar depression without trigger mania . This study examine whether lisdexamfetamine improve depressive symptom course eight week . Lisdexamfetamine prodrug stimulant currently approve attention deficit hyperactivity disorder ( ADHD ) . Participants take study drug placebo addition mood stabilizer . The study include functional magnetic resonance image magnetic resonance spectroscopy determine whether medication alters response affective stimulus glutamate , glutamine , gamma aminobutyric acid ( GABA ) level . Neuropsychological testing also include determine whether study drug improve memory attention population . The primary hypothesis lisdexamfetamine clinically effective population . The secondary hypothesis result increase response affective stimulus alter neurotransmitter level anterior cingulate cortex .</brief_summary>
	<brief_title>Magnetic Resonance Imaging Study Lisdexamfetamine Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>Aged 21 50 year . Diagnosed Bipolar Disorder I II disorder . Currently depressive phase illness . Montgomery Asberg Depression Rating Scale ( MADRS ) score great 15 . Medication regimen ( Lamotrigine , Valproate , Lithium , either alone combination atypical antipsychotic , typical antipsychotic ) stable dos least one month . Has establish residence phone . Capable provide informed consent . Met Diagnostic Statistical Manual 4th edition ( DSMIVTR ) criterion rapid cycling within 6 month prior enrol study . Meets DSMIVTR criterion Schizophrenia , Schizoaffective disorder , PostTraumatic Stress disorder , ObsessiveCompulsive disorder , Eating disorder . Comorbid anxiety disorder reason exclusion . History psychotic symptom point subject 's illness . Met DSMIVTR criterion alcohol substance ( except nicotine ) dependence abuse within past 6 month . Lifetime history amphetamine abuse dependence . Subject lifetime history stimulantinduced mania History seizure , include febrile seizure childhood . Young Mania Rating Scale ( YMRS ) great 8 . History significant coronary artery disease , angina , untreated inadequately treat thyroid disease ( less 1 month chemically euthyroid ) , type I diabetes , autoimmune disease , glaucoma , hypertension , seizure , medical condition ( ) opinion principal investigator likely significantly impact subject 's mood potential response study medication . Electrocardiogram ( ECG ) significant arrhythmias conduction abnormality , opinion physician investigator preclude study participation ; uncontrolled hypertension ( &gt; 160/100 ) tachycardia ( heart rate &gt; 110 ) . Female subject peri postmenopausal . Subjects take Ritalin stimulant , theophylline , steroid , atomoxetine , cholinesterase inhibitor , memantine , modafinil , warfarin , anticonvulsant , clonidine , theophylline , monoamine oxidase inhibitor , pseudoephedrine , medication likely significantly interact ( either pharmacokinetically pharmacodynamically ) subject 's mood Lisdexamfetamine . Subject regularly ( 4 day per week ) ingest four caffeine contain drink per day . Pregnancy . In woman childbearing potential , unwillingness avoid pregnancy duration study . Active suicidal ideation . History homicidal ideation . Allergy clinical condition prohibits use approve mood stabilizer Lisdexamfetamine . Metal body ( e.g . history work sheet metal worker ) pacemaker contraindication magnetic resonance imaging ( MRI ) . Significant claustrophobia .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>lisdexamfetamine</keyword>
	<keyword>vyvanse</keyword>
	<keyword>bipolar disorder</keyword>
	<keyword>depression</keyword>
	<keyword>stimulant</keyword>
	<keyword>magnetic resonance spectroscopy</keyword>
	<keyword>functional magnetic resonance imaging</keyword>
	<keyword>neuropsychological testing</keyword>
</DOC>